Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$42.3B
sum of reported positions
Reported positions
227
Changes vs prior quarter
244
33 new · 48 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 284 measured positions in 8 quarters, the typical new or larger position finished −1.8 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $28.2B | $42.3B |
| Positions | 242 | 227 |
| Biggest line | — | Apple 7% |
| 5.56M |
| $1.99B |
| 4.7% |
| 2.84M | $1.65B | 3.9% |
| 1.22M | $1.41B | 3.3% |
| 493K | $1.12B | 2.7% |
| 2.36M | $1.02B | 2.4% |
| 984K | $950M | 2.2% |
| 6.71M | $937M | 2.2% |
| 2.93M | $883M | 2.1% |
| 2.13M | $805M | 1.9% |
| 3.06M | $781M | 1.8% |
| 1.92M | $685M | 1.6% |
| 1.57M | $617M | 1.5% |
| 1.73M | $611M | 1.4% |
| 1.67M | $570M | 1.3% |
| 939K | $529M | 1.3% |
| 793K | $507M | 1.2% |
| 1.56M | $451M | 1.1% |
| 2.53M | $430M | 1.0% |
| 1.15M | $418M | 1.0% |
| 538K | $411M | 1.0% |
| 2.49M | $404M | 1.0% |
| 1.97M | $368M | 0.9% |
SNOWFLAKE INC
5M shares in Q1 2026
PINNACLE WEST CAP CORP
4.5M shares in Q1 2026
COGENT BIOSCIENCES INC
3.7M shares in Q1 2026
ASCENDIS PHARMA A/S
3.5M shares in Q1 2026
ETSY INC
3M shares in Q1 2026
LI AUTO INC
2.5M shares in Q1 2026
BURLINGTON STORES INC
2.5M shares in Q1 2026
SPHERE ENTERTAINMENT CO
2M shares in Q1 2026
FORTUNA MNG CORP
2M shares in Q1 2026
NUVALENT INC
1.83M shares in Q1 2026
SOLENO THERAPEUTICS INC
1.7M shares in Q1 2026
Olema Pharmaceuticals (OLMA)
1.6M shares in Q1 2026
RIVIAN AUTOMOTIVE INC
1.5M shares in Q1 2026
Shopify (SHOP)
1.44M shares in Q1 2026
ENGENE HOLDINGS INC
1.22M shares in Q1 2026
Everpure (P)
1.13M shares in Q1 2026
Corvus Pharmaceuticals (CRVS)
1.07M shares in Q1 2026
LIBERTY MEDIA CORP DEL
1M shares in Q1 2026
Palantir (PLTR)
867K shares in Q1 2026
Immunome (IMNM)
849K shares in Q1 2026
Ciena (CIEN)
798K shares in Q1 2026
CELCUITY INC
750K shares in Q1 2026
Viavi Solutions (VIAV)
681K shares in Q1 2026
ASCENDIS PHARMA A/S
652K shares in Q1 2026
DATADOG INC
600K shares in Q1 2026